Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

as grindeks krustpils iela 53 lv-1057 riga (letland) - lenalidomideammoniumchloride 3 mg/stuk samenstelling overeenkomend met ; lenalidomide 2,5 mg/stuk - capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; lactose 0-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt, ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; lactose 0-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt - lenalidomide

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

as grindeks krustpils iela 53 lv-1057 riga (letland) - lenalidomideammoniumchloride 24,1 mg/stuk samenstelling overeenkomend met ; lenalidomide 20 mg/stuk - capsule, hard - ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460(i)) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; lactose 0-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt, ammonia (e 527) ; briljantblauw fcf (e 133) ; cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; gelatine (e 441) ; ijzeroxide geel (e 172) ; ijzeroxide zwart (e 172) ; kaliumhydroxide (e 525) ; lactose 0-water ; magnesiumstearaat (e 470b) ; propyleenglycol (e 1520) ; schellak (e 904) ; titaandioxide (e 171) ; zwarte inkt - lenalidomide

Evrópusambandið - hollenska - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotische middelen - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. - capecitabine - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - capecitabine

Holland - hollenska - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

mylan b.v. - capecitabine - filmomhulde tablet - cellulose, microkristallijn (e 460) ; croscarmellose natrium (e 468) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; ijzeroxide geel (e 172) ; ijzeroxide rood (e 172) ; macrogol 400 ; magnesiumstearaat (e 470b) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - capecitabine

Belgía - hollenska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - lisinoprildihydraat 5,44 mg - eq. lisinopril 5 mg - tablet - 5 mg - lisinoprildihydraat 5.44 mg - lisinopril

Belgía - hollenska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - lisinoprildihydraat 21,78 mg - eq. lisinopril 20 mg - tablet - 20 mg - lisinoprildihydraat 21.78 mg - lisinopril

Belgía - hollenska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - temozolomide 5 mg - capsule, hard - 5 mg - temozolomide 5 mg - temozolomide

Belgía - hollenska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - temozolomide 20 mg - capsule, hard - 20 mg - temozolomide 20 mg - temozolomide

Belgía - hollenska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - temozolomide 100 mg - capsule, hard - 100 mg - temozolomide 100 mg - temozolomide